We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Study Finds Chatbot Reduced Problematic Substance Use During Pandemic content piece image
Product News

Study Finds Chatbot Reduced Problematic Substance Use During Pandemic

Woebot Health has announced that the Journal of Medical Internet Research (JMIR), has published the results of its latest study. The study is one of the first to explore substance use disorder interventions via mobile apps.
SignalChem and Merck Collaborate To Evaluate AXL Inhibitor and Keytruda in Advanced NSCLC content piece image
Product News

SignalChem and Merck Collaborate To Evaluate AXL Inhibitor and Keytruda in Advanced NSCLC

SignalChem Lifesciences announces a collaboration with Merck to evaluate the combination of SLC-391, a selective AXL inhibitor, with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC).
Peli BioThermal Broadens Portfolio of Dry Ice Shippers content piece image
Product News

Peli BioThermal Broadens Portfolio of Dry Ice Shippers

Peli BioThermal has announced expanded dry ice shipper options to support exponential growth in cell and gene therapy shipments worldwide, as well as the continued need to transport pandemic payloads.
SGD Pharma Elevates Type I Offerings  content piece image
Product News

SGD Pharma Elevates Type I Offerings

SGD Pharma has introduced an industry-first offering of Type I molded glass vials. These market-driven value propositions represent the latest step in SGD Pharma’s ongoing improvements to its product offers and services.
Thermo Fisher Scientific Collaborates with Artificial To Accelerate COVID-19 Diagnostics content piece image
Product News

Thermo Fisher Scientific Collaborates with Artificial To Accelerate COVID-19 Diagnostics

Thermo Fisher Scientific and Artificial have announced a collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher’s standardized COVID-19 Testing Platform. The integration will result in increased testing throughput and support global healthcare initiatives.
IONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies content piece image
Product News

IONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies

IONTAS and FairJourney Biologics have announced the identification of neutralizing antibodies, which bind to multiple emerging SARS-CoV-2 variants. This identification has allowed for the development of a panel of therapeutic candidates.
Poll Shows 68% of Britons Want An End to Animal Experiments in Medical Research content piece image
Product News

Poll Shows 68% of Britons Want An End to Animal Experiments in Medical Research

Over two-thirds of Britons – 68% – want an end to animal experiments in medical research in UK labs, a new poll reveals. The YouGov survey showed strong public support for ending animal experiments and replacing them with non-animal alternatives, such as artificial intelligence and using human cells or tissues.
Insightful Science and Dotmatics to Form a Cloud-First Scientific R&D Company content piece image
Product News

Insightful Science and Dotmatics to Form a Cloud-First Scientific R&D Company

Insightful Science has announced that it has entered into a transaction to acquire Dotmatics. By integrating Insightful Science’s software applications into Dotmatics cloud-first enterprise data management solution, the company will provide an end-to-end scientific research platform.
Laboratories in Times of Social Distancing and Remote Work content piece image
Product News

Laboratories in Times of Social Distancing and Remote Work

In order to meet the new demands and overcome challenges in laboratories worldwide, Eppendorf offers smart lab management software solutions for laboratory management, such as the VisioNize® Lab Suite, which enhance productivity for all routine tasks in the laboratory.
MicrosensDx RapiPRO™ LAMP for SARS-CoV-2 Receives CE Mark Approval content piece image
Product News

MicrosensDx RapiPRO™ LAMP for SARS-CoV-2 Receives CE Mark Approval

Pioneering British biotech MicrosensDx has announced that its RapiPRO™ LAMP SARS-CoV-2 test has received CE Certification.
Advertisement